文献速递产科

剖宫产术后预防性负压伤口治疗与手术部位感染风险降低相关:系统综述与荟萃分析

Prophylactic negative-pressure wound therapy after cesarean is associated with reduced risk of surgical site infection: a systematic review and meta-analysis.
PubMed 文献 · Am J Obstet Gynecol · 2017-09-23

该系统综述与荟萃分析纳入6项随机对照试验和3项队列研究,对象多为肥胖高危产妇,比较剖宫产术后预防性负压伤口治疗与标准伤口敷料。预防性负压伤口治疗与手术部位感染风险显著降低相关(7项研究:合并风险比0.45,95%CI 0.31-0.66),复合伤口并发症也显著减少(9项研究:合并风险比0.68,95%CI 0.49-0.94)。作者认为需要更大规模的确证性试验来明确其临床效用。

要点

  • 预防性负压伤口治疗与剖宫产术后手术部位感染风险降低相关(合并RR 0.45,95%CI 0.31-0.66)。
  • 预防性负压伤口治疗与复合伤口并发症减少相关(合并RR 0.68,95%CI 0.49-0.94)。
  • 作者认为需要更大规模的确证性试验来明确剖宫产术后预防性负压伤口治疗的临床效用。

核心结论

  • 剖宫产术后预防性负压伤口治疗的研究异质性较大,但结果提示可降低手术部位感染和总体伤口并发症。
  • 作者认为需要更大规模的确证性试验来明确剖宫产术后预防性负压伤口治疗的临床效用。

研究设计与样本

  • 系统综述与荟萃分析,纳入比较剖宫产术后预防性负压伤口治疗与标准伤口敷料的随机对照试验和观察性研究。
  • 共纳入6项随机对照试验和3项队列研究,对象多为肥胖高危产妇;其中6篇全文、2篇摘要、1项ClinicalTrials.gov试验结果报告。
  • 检索Ovid Medline、Embase、SCOPUS、Cochrane系统综述数据库和ClinicalTrials.gov。
  • 主要结局为剖宫产术后手术部位感染;次要结局为复合伤口并发症、伤口裂开、伤口血清肿、子宫内膜炎和再入院。
  • 采用Higgin's I2评估异质性,使用随机效应模型计算相对风险及95%置信区间。

主要发现

  • 预防性负压伤口治疗组手术部位感染风险显著低于标准伤口敷料组(7项研究:合并风险比0.45,95%CI 0.31-0.66;调整风险比-6.0%,95%CI -10.0%至-3.0%;需治疗人数17,95%CI 10-34)。
  • 未发现显著统计学异质性(I2=9.9%)或发表偏倚(Egger P=0.532)。
  • 次要结局中仅复合伤口并发症在预防性负压伤口治疗组显著减少(9项研究:合并风险比0.68,95%CI 0.49-0.94)。

临床怎么用

  • 原文未据此给出推荐。
  • 作者认为需要更大规模的确证性试验来明确剖宫产术后预防性负压伤口治疗的临床效用。

局限性

  • 研究在纳入患者和负压伤口治疗装置类型方面存在异质性。
  • 作者认为需要更大规模的确证性试验来明确剖宫产术后预防性负压伤口治疗的临床效用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The objective of the study was to assess the effect of prophylactic negative-pressure wound therapy on surgical site infections and other wound complications in women after cesarean delivery. DATA SOURCES: We searched Ovid Medline, Embase, SCOPUS, Cochrane Database of Systematic Reviews, and ClinicalTrials.gov. STUDY ELIGIBILITY CRITERIA: We included randomized controlled trials and observational studies comparing prophylactic negative-pressure wound therapy with standard wound dressing for cesarean delivery. STUDY APPRAISAL AND SYNTHESIS METHODS: The primary outcome was surgical site infection after cesarean delivery. Secondary outcomes were composite wound complications, wound dehiscence, wound seroma, endometritis, and hospital readmission. Heterogeneity was assessed using Higgin's I2. Relative risks with 95% confidence intervals were calculated using random-effects models. RESULTS: Six randomized controlled trials and 3 cohort studies in high-risk mostly obese women met inclusion criteria and were included in the meta-analysis. Six were full-text articles, 2 published abstracts, and 1 report of trial results in ClinicalTrials.gov. Studies were also heterogeneous in the patients included and type of negative-pressure wound therapy device. The risk of surgical site infection was significantly lower with the use of prophylactic negative-pressure wound therapy compared with standard wound dressing (7 studies: pooled risk ratio, 0.45; 95% confidence interval, 0.31-0.66; adjusted risk ratio, -6.0%, 95% confidence interval, -10.0% to -3.0%; number needed to treat, 17, 95% confidence interval, 10-34). There was no evidence of significant statistical heterogeneity (I2 = 9.9%) or publication bias (Egger P = .532). Of the secondary outcomes, only composite wound complications were significantly reduced in patients receiving prophylactic negative-pressure wound therapy compared with standard dressing (9 studies: pooled risk ratio, 0.68, 95% confidence interval, 0.49-0.94). CONCLUSION: Studies on the effectiveness of prophylactic negative-pressure wound therapy at cesarean delivery are heterogeneous but suggest a reduction in surgical site infection and overall wound complications. Larger definitive trials are needed to clarify the clinical utility of prophylactic negative-pressure wound therapy after cesarean delivery.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Yu L, Kronen RJ, Simon LE, et al. Prophylactic negative-pressure wound therapy after cesarean is associated with reduced risk of surgical site infection: a systematic review and meta-analysis. Am J Obstet Gynecol. 2017. PMID: 28951263. doi:10.1016/j.ajog.2017.09.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。